Behavioural determinants of obesity

Kirsten L Rennie1, Laura Johnson, Susan A Jebb

  • 1MRC Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK. klr1000@cam.ac.uk

Insights

Childhood obesity stems from genetics and behavior, like diet and activity. More research is needed to understand behavioral factors and guide interventions for preventing excess weight gain.

Area of Science:

  • Pediatric Health
  • Behavioral Science
  • Public Health

Background:

  • Childhood obesity results from a complex interaction between genetic predisposition and behavioral factors, particularly diet and physical activity.
  • Limited evidence exists on specific behavioral factors influencing childhood weight gain, with unclear effects of growth and development.

Purpose of the Study:

  • To review and synthesize evidence on behavioral risk factors associated with childhood obesity.
  • To identify gaps in current research and highlight the need for more robust evidence to inform interventions.

Main Methods:

  • Review of existing literature, primarily cross-sectional studies, examining behavioral factors and childhood weight gain.
  • Identification of postulated behavioral risk factors including energy density of diet, sugar-sweetened beverage consumption, portion sizes, eating patterns, sedentary behavior, and physical activity levels.

Main Results:

  • Evidence for specific behavioral factors is limited and often yields conflicting results due to reliance on cross-sectional data.
  • Postulated risk factors include high-energy-density diets, sugar-sweetened beverages, large portion sizes, and low physical activity.

Conclusions:

  • More prospective studies with accurate measures of exposures and body composition are essential.
  • Robust evidence is needed to develop effective interventions for long-term behavioral change and prevention of childhood excess weight gain.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Causes of Social Behavior III: Biological and Environmental Influences01:28

Causes of Social Behavior III: Biological and Environmental Influences

Social behavior is a complex phenomenon that arises from the interaction between biological predispositions and environmental influences. This intricate interplay shapes how individuals think, feel, and act in various social contexts. Understanding these mechanisms requires insights from psychology, neuroscience, genetics, and evolutionary theory.Environmental Influences on Social BehaviorEnvironmental factors, including temperature, odors, and visual stimuli, play a crucial role in shaping...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...